Oxygen levels linked to surgical leaks in esophageal cancer patients
NCT ID NCT07309991
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether low oxygen levels after esophageal cancer surgery increase the chance of a leak where the esophagus is reconnected. Researchers reviewed records of 2,083 patients, comparing those with low oxygen to those with normal levels. The goal was to see if correcting low oxygen could help prevent this serious complication.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 2,500 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2021
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
This retrospective cohort study included patients diagnosed with esophageal carcinoma or benign esophageal tumors who required surgical resection of the lesion followed by esophageal reconstruction. All patients had at least one postoperative arterial blood gas analysis, and anastomotic healing was assessed via esophagram, CT scan, endoscopy, or typical clinical sign.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients diagnosed with esophageal carcinoma or benign esophageal tumors * Patients requiring surgical resection of the lesion with subsequent esophageal reconstruction * Patients must have had at least one postoperative arterial blood gas analysis * Patients must have routinely undergone at least one of the following for postoperative evaluation of the anastomosis: endoscopy, CT scan, or esophagram Exclusion Criteria: * Patients who did not require esophageal reconstruction * Patients undergoing esophageal replacement with colon * Patients with incomplete data
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Benign esophageal tumor are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
6 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
0817-2598459
RECRUITINGNanchong, Sichuan, China
-
Cancer Hospital of Shantou University Medical College
RECRUITINGShantou, Guangdong, China
-
Department of Thoracic Surgery, Sun Yat-sen University Cancer Center
RECRUITINGGuangzhou, Guangdong, 510060, China
-
Shanghai Chest Hospital
RECRUITINGShanghai, Shanghai Municipality, China
-
Sichuan Cancer Hospital
RECRUITINGChengdu, Sichuan, China
-
The Fourth Hospital of Hebei Medical University and Hebei Tumor Hospital
RECRUITINGShijiazhuang, Hebei, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Patient's own blood turned into surgical glue to stop deadly leaks
- Swallowable capsule and lab test take on endoscopy for esophageal cancer screening
- Blood proteins may predict who beats esophageal cancer with chemoradiation
- Can a direct hit to tumors make immunotherapy work better?
- Can a new drug boost immunotherapy against Hard-to-Treat stomach cancer?
- Blood test aims to catch Cancer's return earlier